Infectious Diseases

Oxford COVID Vaccine Could be Hampered by Adenovirus Immunity

30 July 2020

  • The ChAdOx1 vaccine is a chimpanzee adenovirus modified to produce the Sars-CoV-1 spike protein.
  • Acquired resistance to adenoviruses may impair the effectiveness of the ChAdOx1
  • Most of the world has between 50 and 60% immunity to adenoviruses
  • It may be possible to engineer adenoviruses to hide from the immune system while producing coronavirus proteins
  • Studies investigating vaccine effectiveness are difficult to compare, as they use different methods to measure immunity.
  • The ‘ideal’ vaccine would induce neutralising antibodies of multiple subtypes (IgG, IgM, IgA).

Featured in This Post

Never Miss a Breakthrough!

Sign up for our newletter and get the latest breakthroughs direct to your inbox.

Checkout the Gowing Life Store

Scientifically Developed Blended Vitamins, and Exclusive Supplements For Health, and Longevity

Copyright © Gowing Life Limited, 2022 • All rights reserved • Registered in England & Wales No. 11774353 • Registered office: Ivy Business Centre, Crown Street, Manchester, M35 9BG.